Key result
Interferon-beta remains a recognized therapeutic option for multiple sclerosis, though clinical response is only partial and optimal dosing regimens are not fully elucidated.
Why the study?
What is the clinical efficacy and mechanism of action of Interferon-beta in the treatment of relapsing multiple sclerosis?
What is the clinical efficacy and mechanism of action of Interferon-beta in the treatment of relapsing multiple sclerosis?
Interferon-beta remains a recognized and approved therapeutic option for relapsing multiple sclerosis, primarily through immunomodulatory effects, despite partial clinical responses.
May guide IFN-beta product selection in MS; leaves open strategies for partial responders.
BACKGROUND: Recombinant forms of IFN-beta were the first therapeutic intervention found to be effective at interfering with the course of multiple sclerosis (MS), a chronic and debilitating disease affecting the CNS in young adults. OBJECTIVE/METHODS: To examine the application of IFN-beta to MS treatment by a review of relevant literature. RESULTS: The different IFN-beta products available are similar in their clinical effects. However, the response to IFN-beta therapy is only partial and the most efficient individual-specific dose, route and frequency of administration are not elucidated fully. The mechanism of action of IFN-beta in MS is also not understood fully but its immunomodulatory effects are probably more important than its anti-proliferative and antiviral activities. CONCLUSIONS: Although new therapeutic approaches are being sought to better treat MS, IFN-beta remains one of the most recognized and approved worldwide therapeutic options for this disease.
No takes yet. Share an insight, caveat, or question.
Weinstock‐Guttman et al. (2008) conducted a review in Relapsing multiple sclerosis. Interferon-beta was evaluated. Interferon-beta remains a recognized therapeutic option for multiple sclerosis, though clinical response is only partial and optimal dosing regimens are not fully elucidated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: